Ngā hua rapu - Barry S. Coller

Whakamahine hua
  1. 1
    αIIbβ3: structure and function

    αIIbβ3: structure and function mā Barry S. Coller

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Historical perspective and future directions in platelet research

    Historical perspective and future directions in platelet research mā Barry S. Coller

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    The Effects of Ristocetin and von Willebrand Factor on Platelet Electrophoretic Mobility

    The Effects of Ristocetin and von Willebrand Factor on Platelet Electrophoretic Mobility mā Barry S. Coller

    I whakaputaina 1978
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.

    Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. mā Barry S. Coller

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.

    A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. mā Barry S. Coller

    I whakaputaina 1985
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality

    Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality mā Barry S. Coller

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Monitoring Platelet GP IIb/IIIa Antagonist Therapy

    Monitoring Platelet GP IIb/IIIa Antagonist Therapy mā Barry S. Coller

    I whakaputaina 1998
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Embedding a Commitment to Equitable Global Access into Basic and Early-Phase Translational Research

    Embedding a Commitment to Equitable Global Access into Basic and Early-Phase Translational Research mā Barry S. Coller

    I whakaputaina 2025
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Studies on the Mechanism of Ristocetin-Induced Platelet Agglutination

    Studies on the Mechanism of Ristocetin-Induced Platelet Agglutination mā Barry S. Coller, Harvey R. Gralnick

    I whakaputaina 1977
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend

    The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend mā Barry S. Coller, Sanford J. Shattil

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Traversing the Valley of Death: A Guide to Assessing Prospects for Translational Success

    Traversing the Valley of Death: A Guide to Assessing Prospects for Translational Success mā Barry S. Coller, Robert M. Califf

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Ligand density dramatically affects integrin αIIbβ3-mediated platelet signaling and spreading

    Ligand density dramatically affects integrin αIIbβ3-mediated platelet signaling and spreading mā Markéta Jiroušková, Jyoti K. Jaiswal, Barry S. Coller

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.

    Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. mā H R Grainick, Sybil B. Williams, Barry S. Coller

    I whakaputaina 1985
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel.

    The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. mā PJ Newman, Uri Seligsohn, Suzanne Lyman, Barry S. Coller

    I whakaputaina 1991
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Application of high-throughput screening to identify a novel αIIb-specific small- molecule inhibitor of αIIbβ3-mediated platelet interaction with fibrinogen

    Application of high-throughput screening to identify a novel αIIb-specific small- molecule inhibitor of αIIbβ3-mediated platelet interaction with fibrinogen mā Robert Blue, Marta Murcia, Charles Karan, Markéta Jiroušková, Barry S. Coller

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Evidence that glycocalicin circulates in normal plasma.

    Evidence that glycocalicin circulates in normal plasma. mā Barry S. Coller, E L Kalomiris, M Steinberg, L E Scudder

    I whakaputaina 1984
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Variable protection of β3-integrin–deficient mice from thrombosis initiated by different mechanisms

    Variable protection of β3-integrin–deficient mice from thrombosis initiated by different mechanisms mā Susan S. Smyth, Ernane D. Reis, Heikki Väänänen, Wen Zhang, Barry S. Coller

    I whakaputaina 2001
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Three-dimensional reconstruction of intact human integrin αIIbβ3: new implications for activation-dependent ligand binding

    Three-dimensional reconstruction of intact human integrin αIIbβ3: new implications for activation-dependent ligand binding mā Won Suk Choi, William J. Rice, David L. Stokes, Barry S. Coller

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm

    Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm mā Aslıhan Turhan, Linnea A. Weiss, Narla Mohandas, Barry S. Coller, Paul S. Frenette

    I whakaputaina 2002
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

    A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb a... mā Barry S. Coller, Ellinor I.B. Peerschke, L E Scudder, Christopher A. Sullivan

    I whakaputaina 1983
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: